Evidence map›Paper›PMID 39891606›Full record

ArticleEpilepsia open2025

Communicating a diagnosis of Dravet syndrome to parents/caregivers: An international Delphi consensus.

Andreas Brunklaus, Susanne Schubert-Bast, Francesca Darra, Katherine Nickels, Delphine Breuillard, Andrea Giuffrida, Claire Eldred, Silke Flege, Elena Cardenal-Muñoz, Rocío Sánchez-Carpintero

Abstract readConsensus Statement
In one paragraph

Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Andreas BrunklausSchool of Health and Wellbeing, University of Glasgow, Glasgow, UK.ORCID https://orcid.org/0000-0002-7728-6903
Susanne Schubert-BastGoethe-University Frankfurt, Epilepsy Centre Frankfurt Rhine-Main, Frankfurt am Main, Germany.ORCID https://orcid.org/0000-0003-1545-7364
Francesca DarraChild Neuropsychiatry Unit, Department of Engineering for Innovation Medicine, University of Verona (Full Member of European Reference Network EpiCARE), Verona, Italy.ORCID https://orcid.org/0000-0002-1062-8438
Katherine NickelsMayo Clinic, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0002-6579-3035
Delphine BreuillardReference Center for Rare Epilepsies, Necker Hospital, AP-HP, Paris, France.ORCID https://orcid.org/0009-0000-6317-900X
Andrea GiuffridaBambino Gesù Children's Hospital, Rome, Italy.
Claire EldredDravet Syndrome UK, Chesterfield, UK.ORCID https://orcid.org/0000-0001-8957-9044
Silke FlegeDravet-Syndrom e.V., Frankfurt, Germany.
Elena Cardenal-MuñozBiocodex Medical Affairs, Gentilly, France.ORCID https://orcid.org/0000-0003-4757-9323
Rocío Sánchez-CarpinteroClínica Universidad de Navarra, Pamplona, Spain.ORCID https://orcid.org/0000-0002-5058-0686

Funding

Biocodex
6 · The paper itself

Abstract

objectiveDravet syndrome is a developmental and epileptic encephalopathy characterized by drug-resistance, lifelong seizures, and significant comorbidities including intellectual and motor impairment. Receiving a diagnosis of Dravet syndrome is challenging for parents/caregivers, and little research has focused on how the diagnosis should be given. A Delphi consensus process was undertaken to determine key aspects for healthcare professionals (HCPs) to consider when communicating a Dravet syndrome diagnosis to parents/caregivers.

methodsFollowing a literature search and steering committee review, 34 statements relating to the first diagnosis consultation were independent- and anonymously voted on (from 1, totally inappropriate, to 9, totally appropriate) by an international group of expert child neurologists, neuropsychiatrists, nurses, and patient advisory group (PAG) representatives. The statements were divided into five chapters: (i) communication during the first diagnosis consultation, (ii) information to be delivered during the first diagnosis consultation, (iii) points to be reiterated at the end of the first diagnosis consultation, (iv) information to be delivered at subsequent consultations, and (v) communication around genetic testing. Statements receiving ≥ 75% of the votes with a score of ≥7 and/or with a median score of ≥8 were considered consensual.

resultsThe statements were evaluated by 44 HCPs and PAG representatives in the first round of voting; 29 statements obtained strong consensus, 3 received good consensus, and 2 did not reach consensus. The committee reformulated and resubmitted 4 statements for evaluation (42/44 voters): 3 obtained strong consensus and 1 remained not consensual. The final consensual recommendations include guidance on consultation setting, key disease aspects to convey, how to discuss genetic testing results, disease evolution, and the risk of SUDEP, among other topics. SIGNIFICANCE: It is hoped that this international Delphi consensus will facilitate a better-structured initial diagnosis consultation and offer further support for parents/caregivers at this challenging time of learning about Dravet syndrome. PLAIN LANGUAGE SUMMARY: Diagnosis of Dravet syndrome, a rare and severe form of childhood-onset epilepsy, is often challenging to give to parents. This international study developed guidance and recommendations to help healthcare professionals better structure and personalize this disclosure. By following this advice, doctors can provide more tailored support to families, improving their understanding and management of the condition.

Indexed as

CaregiversCommunicationEpilepsies, MyoclonicParentsDelphi TechniqueGenetic TestingHumansbest practice recommendationsDelphi consensusdiagnosis communicationDravet syndromehealthcare professional‐patient relationship

Identifiers

PMID39891606
PMCPMC12014930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.